MariMed Inc. Insider Trading

MRMD

⊜ Compare

Last 12 months

Insiders bought 13K on the open market and sold nothing.

Net open-market

+13K

3 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

2 / 0

executives and directors

Last open-market buy

May 2026

May 22, 2026

Get an email when MRMD's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 22	Jon R Levine President and CEO	Bought 3 parts	60,000	$0.08 average	5K	0.2%	Form 4
May 20	Jon R Levine President and CEO	Bought	40,000	$0.08	3K	0.1%	Form 4
Dec 12, 2025	Timothy Shaw Chief Operating Officer	Bought	45,455	$0.11	5K	0.4%	Form 4

May 22
Jon R Levine
President and CEO · bought 60,000 at avg $0.08
5K
0.2% of stake
May 20
Jon R Levine
President and CEO · bought 40,000 at $0.08
3K
0.1% of stake
Dec 12, 2025
Timothy Shaw
Chief Operating Officer · bought 45,455 at $0.11
5K
0.4% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MRMD, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Medicinal Chemicals & Botanical Products · Pick stocks to compare with MRMD

CompareIntrinsic value

CRONCronos Group Inc.

$3.51+3.85%81

BTMDBiote Corp.

$1.23+9.38%53

NAIINatural Alternatives International Inc.

$1.10+3.77%3

NAGENiagen Bioscience Inc.

$2.52+6.78%61

MTEXMannatech, Incorporated

$8.64-0.12%52

FTLFFitLife Brands, Inc.

$8.18+3.68%80

JUSHFJushi Holdings Inc.

C$0.66-8.33%39

LEEEFLeef Brands Inc.

$0.17+9.74%30

Spot a number that looks wrong? Check it in MRMD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MRMD

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.